In recent years, new single cell technologies have revolutionized our understanding of cell identity and diversity and enabled research to be carried out at an unprecedented resolution. The shift from bulk to single cell methods has paved the way for new and exciting research to reveal novel insights in a wide spectrum of biological fields.

In this webinar we will provide an overview of the Dolomite Bio and Illumina platforms, as well as the workflow, which when coupled together, provides an end-to-end solution for varying cell types, sizes and applications. We are also pleased to be joined by guest speaker Aki Minoda from RIKEN, who will discuss her research using the platforms and how it is has been key in optimising and developing experiments within projects such as mouse ageing and plant studies. Join us to see how customisable single-cell workflows are within your reach and gain insight into the ongoing research at the Laboratory for Cellular and Epigenomics using single cell platforms.

	Dr. Aki Minoda Team leader at Laboratory Cellular Epigenomics RIKEN Center for Integrative Medical Sciences
	She will describe: Background into the groups areas of research including: Chromatin and transcription landscaping in various models. Single cell omics projects such as mouse ageing and plant studies. What platforms are used for each type of study. Optimization of conditions and data generation using the Nadia Innovate for scRNA-Seq and sNuc-seq. An overview of platform benefits.
	Dr. Thomas Ayers Technical Applications Specialist Dolomite Bio
	He will cover: The Nadia Instrument for scRNA-seq and sNuc-seq. The Nadia Innovate for novel protocol development. A full workflow overview from cells to data.
	Lei Tong Senior Regional Marketing Manager Illumina
	She will describe: Overview of Illumina sequencing platforms. Experiment planning for Single-cell NGS. Newest updates on Illumina sequencing technology and the benefits to Single-cell research.

* This webinar is conducted by Illumina in collaboration with Dolomite Bio.